Conflicting signals on US accelerated approvals

被引：0

作者：

Jeffrey L Fox

机构：

来源：

Nature Biotechnology | 2005年 / 23卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

While the FDA waits for someone to come up with a plan to improve the accelerated approval program, some argue that as it is, drugs are not getting to the people who need them.

引用

页码：1027 / 1028

页数：1

共 50 条

[1] Conflicting signals on US accelerated approvals
Fox, JL
[J]. NATURE BIOTECHNOLOGY, 2005, 23 (09) : 1027 - 1028
[2] ARE FDA ACCELERATED APPROVALS UNCONDITIONAL APPROVALS?
Macaulay, R.
Tsang, R.
[J]. VALUE IN HEALTH, 2018, 21 : S94 - S94
[3] Study bolsters concerns about US FDA accelerated drug approvals
Furlow, Bryant
[J]. LANCET ONCOLOGY, 2024, 25 (05): : 543 - 543
[4] Accelerated approvals examined
Emma Dorey
[J]. Nature Biotechnology, 2011, 29 (3) : 176 - 176
[5] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
Lemery, Steven
Pazdur, Richard
[J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
[6] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
Steven Lemery
Richard Pazdur
[J]. Nature Reviews Clinical Oncology, 2022, 19 : 217 - 218
[7] Accelerated approvals under the microscope
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (06) : 409 - 411
[8] "Dangling" Accelerated Approvals in Oncology
Beaver, Julia A.
Pazdur, Richard
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18):
[9] Accelerated approvals under the microscope
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2021, 20 : 409 - 411
[10] CONFLICTING SIGNALS
MILLER, J
[J]. NEW REPUBLIC, 1977, 177 (04) : 10 - 11

← 1 2 3 4 5 →